Patents
The latest patent-related news relating to all sectors of the chemical and pharmaceutical industries, including infringement disputes, expiries and general patent law, from the Royal Society of Chemistry's magazine, Chemistry World
-
FeatureThe curious case of disappearing polymorphs
From crystallographers’ beards to billion-dollar lawsuits, the phenomenon of disappearing polymorphs has puzzled chemists for decades. Now researchers are finally unravelling the science behind why stable crystal forms suddenly vanish – and discovering how to bring them back
-
OpinionIndia’s generic semaglutide surge
As patents on Novo Nordisk’s diabetes and weight loss blockbusters expire, generic makers have their versions ready
-
ResearchAI tool paints bigger picture of global impact of millions of research grants, papers and patents
Team behind Funding the Frontier hope it will help funders and policymakers make better decisions but others worry system might favour ‘safe’ research
-
-
OpinionWeight loss drug supply races
With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of drugs
-
NewsDisappointing AI judgment could have a ‘catastrophic effect’ on UK science
Warnings that loose legal definitions in case could also threaten innovation in chemistry
-
BusinessExplainer: How is the US pharmaceutical patent system being misused?
What are ‘evergreening’ and ‘thicketing’ and what is being done to reform the system and aid competition?
-
NewsLandmark intellectual property ruling could offer new opportunities for chemists working with AI
UK court’s decision that an artificial neural network can be patented could have widespread ramifications
-
NewsEuropean intellectual property system ready for gene-edited crops
Updates to New Genomic Technology regulations irrelevant to IP say experts
-
BusinessUS supreme court confirms Amgen’s cholesterol antibody patents invalid
Decision could mean patent descriptions need to be even more detailed, and hence expensive
-
BusinessPharmaceuticals roundup 2022
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking
-
BusinessEurope gears up for streamlined patent system
Delayed Unified Patent Court set to begin operating in April
-
NewsUS chemical industry responsible for 25% of the country’s GDP
National Academies finds chemical research has ‘outsized economic value’
-
NewsChemistry appears less often in news than biology or medicine
But chemical research has a strong presence in patents, study finds
-
-
BusinessPatent office cements priority for Crispr gene editing in cells
Nobel laureates’ failed challenge means companies may need extra patent licenses
-
-
BusinessUS supreme court ends Sandoz–Amgen biosimilar dispute
Sandoz’s copy of arthritis drug Enbrel won’t be available in the US until 2029, 30 years after it was first marketed
-
-
OpinionRewards based on priority drive unnecessary competition
The story of Crispr illustrates how a focus on patents and publications can cause good people to act in unsavoury ways